The Reggio Emilia study on bromfenac for patients with Pseudo EXfoliation syndrome undergoing cataract surgery: the REPEX study

Trial Profile

The Reggio Emilia study on bromfenac for patients with Pseudo EXfoliation syndrome undergoing cataract surgery: the REPEX study

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Nov 2015

At a glance

  • Drugs Bromfenac (Primary) ; Tobramycin/dexamethasone
  • Indications Ocular inflammation
  • Focus Therapeutic Use
  • Acronyms REPEX Study
  • Most Recent Events

    • 28 Oct 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
    • 07 Oct 2014 New source identified and integrated (ClinicalTrials.gov record, NCT02137161).
    • 01 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top